ADHD medications contain one of a few core active ingredients, each designed to increase the availability of specific chemical messengers in the brain. The two main categories are stimulants (which make up the majority of prescriptions) and non-stimulants, and they work through distinctly different mechanisms. Beyond the active drug itself, every pill, capsule, or patch also contains inactive ingredients that shape how the medication is delivered, how it looks, and how long it lasts.
Stimulant Active Ingredients
Most ADHD medications are built around one of two stimulant compounds: amphetamine or methylphenidate. These are the chemicals doing the actual therapeutic work, and nearly every brand-name ADHD stimulant is a variation on one of them.
Amphetamine exists as two mirror-image molecules: dextroamphetamine and levoamphetamine. Some formulations use only dextroamphetamine, which is the more potent of the two. Others blend both forms together. Adderall, for example, contains a mix of amphetamine and dextroamphetamine salts. Vyvanse takes a different approach: its active ingredient is lisdexamfetamine, which is chemically inactive on its own. Your body has to break it down into dextroamphetamine before it works, which is why Vyvanse has a slower, more gradual onset.
Methylphenidate is the other major stimulant and the active ingredient in Ritalin, Concerta, and several other brands. Though it targets the same brain chemicals as amphetamine, it works in a fundamentally different way at the molecular level.
How Stimulants Work in the Brain
Both stimulant types increase the levels of two chemical messengers: dopamine and norepinephrine. These are concentrated in the prefrontal cortex, the part of your brain responsible for attention, planning, and impulse control. In ADHD, signaling involving these chemicals tends to be underactive.
Methylphenidate works by blocking the transporters that normally vacuum dopamine and norepinephrine back up after they’ve been released. With those recycling mechanisms blocked, more of each chemical stays available in the gaps between brain cells, strengthening the signal. Amphetamine does this too, but it goes a step further: it also triggers neurons to actively push extra dopamine out of their storage compartments. This dual action is why amphetamine-based medications can feel different from methylphenidate-based ones, even though both are classified as stimulants.
Non-Stimulant Active Ingredients
For people who don’t respond well to stimulants or experience problematic side effects, non-stimulant options target the same brain chemistry through different routes.
Atomoxetine (the active ingredient in Strattera) is a selective norepinephrine reuptake inhibitor. It blocks the norepinephrine transporter specifically, keeping more norepinephrine active in the prefrontal cortex. Unlike stimulants, it doesn’t have a significant direct effect on dopamine transporters, which is part of why it carries a lower risk of misuse. It also takes several weeks to reach full effectiveness, compared to the near-immediate action of stimulants.
Viloxazine is a newer non-stimulant that also increases norepinephrine activity, though through a slightly different profile. It’s approved for children and adolescents.
Alpha-2 Agonists
Guanfacine and clonidine belong to a separate class called alpha-2 adrenergic agonists. Rather than blocking reuptake, these medications mimic what norepinephrine does by directly stimulating specific receptors on brain cells in the prefrontal cortex. Guanfacine is more targeted, binding primarily to one receptor subtype (alpha-2A) with 15 to 20 times more affinity than it has for other subtypes. Clonidine is less selective, activating all three alpha-2 receptor subtypes.
These medications are particularly useful for the hyperactivity, impulsivity, and emotional regulation difficulties that come with ADHD, rather than the pure focus and distractibility issues that stimulants address most directly. They’re also sometimes prescribed alongside a stimulant to cover symptoms the stimulant doesn’t fully manage, and clonidine in particular can help with the sleep problems that often accompany ADHD.
Inactive Ingredients in ADHD Pills
The active drug is only one component of any ADHD medication. The rest of the tablet or capsule is made up of inactive ingredients, sometimes called excipients, that serve structural and functional roles. A standard methylphenidate tablet, for instance, contains lactose (a filler that gives the tablet bulk), magnesium stearate (a lubricant that prevents the powder from sticking to manufacturing equipment), microcrystalline cellulose (a binder that holds the tablet together), and sodium starch glycolate (a disintegrant that helps the tablet break apart in your stomach).
Dyes are also common. Different strengths of the same medication use different colors so they can be told apart easily. A 5 mg methylphenidate tablet may contain D&C Yellow #10, while a 20 mg version uses FD&C Yellow #6. These dyes have no therapeutic purpose but are worth knowing about if you have dye sensitivities or allergies.
How Extended-Release Formulations Differ
One of the biggest differences between ADHD medications isn’t the active drug itself but the delivery system that controls when and how it’s released. Immediate-release tablets dissolve quickly and deliver their full dose within about 30 minutes, which is why they typically need to be taken two or three times a day. Extended-release versions use engineering at the pill level to spread that release over 8 to 12 hours.
Concerta uses an osmotic delivery system. The tablet has an immediate-release coating on the outside that dissolves first, providing an initial dose. Underneath, there’s a rigid shell with a tiny laser-drilled hole. As the tablet moves through your digestive tract, water passes through the shell’s membrane into a “push” chamber that slowly swells. This expanding chamber physically pushes the remaining medication out through the hole at a controlled rate over the course of the day. This is why Concerta tablets should never be crushed or split.
Other extended-release capsules use a bead-based system. Inside the capsule are tiny beads with different coatings. Some beads are designed to dissolve in the acidic environment of the stomach (pH around 1.5 to 3.5), releasing an early dose. Other beads have coatings that resist stomach acid but dissolve once they reach the less acidic small intestine (pH around 5.5), releasing a second wave of medication hours later. The ratio of immediate-release to delayed-release beads determines the medication’s overall profile.
Extended-release tablets also have their own set of inactive ingredients tailored to this slower delivery, including cetyl alcohol, ethylcellulose (which forms the controlled-release coating), and anhydrous lactose.
Patch and Liquid Formulations
Not all ADHD medications come as pills. The Daytrana patch delivers methylphenidate through the skin using a layered adhesive system. The drug is dispersed in a combination of acrylic and silicone adhesives, sandwiched between a polyester backing film and a protective liner that you peel off before applying. This transdermal approach bypasses the digestive system entirely, which can be useful for people who have trouble swallowing pills or experience significant stomach-related side effects. The patch allows for some flexibility in dosing duration since removing it stops the absorption.
Liquid formulations of both amphetamine and methylphenidate are also available, primarily for children who can’t swallow tablets or capsules. These use suspension agents and flavoring instead of the binders and fillers found in solid forms.
Generic vs. Brand-Name Ingredients
The FDA requires generic ADHD medications to contain the exact same active ingredient as the brand-name version. Where they can differ is in their inactive ingredients: a generic methylphenidate tablet might use different fillers, binders, or dyes than the brand-name equivalent. Large-scale research comparing generics to brand-name drugs has found absorption differences of only 3% to 5%, which is considered clinically acceptable for most medications.
That said, some people do notice a difference when switching between brands or from brand-name to generic. This is more likely to matter with medications that have a narrow therapeutic window, where small shifts in absorption could push levels slightly above or below the effective range. If you notice a meaningful change in how well your medication works after a switch, the inactive ingredient profile of the new formulation may be worth discussing with your pharmacist.